Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-210
Closed -$10.9K 164
2018
Q1
$10.9K Sell
210
-16
-7% -$864 0.01% 219
2017
Q4
$12.2K Sell
226
-17
-7% -$942 0.01% 251
2017
Q3
$14.9K Sell
243
-2,121
-90% -$129K 0.02% 216
2017
Q2
$145K Buy
2,364
+2,085
+747% +$127K 0.17% 105
2017
Q1
$16.9K Sell
279
-1,559
-85% -$94.6K 0.02% 202
2016
Q4
$103K Buy
1,838
+527
+40% +$30.8K 0.11% 123
2016
Q3
$78.1K Hold
1,311
0.06% 145
2016
Q2
$72.1K Hold
1,311
0.1% 133
2016
Q1
$66.2K Sell
1,311
-139
-10% -$6.81K 0.08% 120
2015
Q4
$73.1K Buy
1,450
+873
+151% +$44K 0.09% 115
2015
Q3
$27.2K Buy
577
+367
+175% +$19.5K 0.06% 127
2015
Q2
$11.4K Hold
210
0.01% 202
2015
Q1
$11.5K Buy
+210
New +$11.9K 0.01% 208

Other funds holding MRK

Risk Paradigm Group's MRK Position: Q2 2018 in Review

Risk Paradigm Group sold out of Merck (MRK) in Q2 2018, closing a stake of 210 shares — an estimated $10.9K sold.

Risk Paradigm Group first reported a position in MRK in Q1 2015 and held it in 13 quarters. The position peaked at $145K in Q2 2017. 2,017 funds tracked by Wall St. Rank hold MRK as of Q2 2018.

  • Risk Paradigm Group reported no remaining Merck position as of Q2 2018 after selling out during the quarter.
  • Risk Paradigm Group sold 210 Merck shares in Q2 2018, an estimated $10.9K.
  • Risk Paradigm Group first reported a position in Merck in Q1 2015 and held it in 13 quarters.
  • Risk Paradigm Group's Merck position peaked at $145K in Q2 2017.
  • 2,017 funds tracked by Wall St. Rank held Merck as of Q2 2018.

Based on Risk Paradigm Group's 13F filing for Q2 2018, filed 10 Aug 2018.